AlzeCure Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 18 shareholders own 51.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.1%	Bwg Invest S.à R.L.	8,747,295	€1.5m	43.9%	no data
7.09%	FV Group AB	4,400,000	€759.7k	57.1%	no data
7.09%	Sjuenda Holding AB	4,400,000	€759.7k	57.1%	no data
3.92%	Avanza Fonder AB	2,436,510	€420.7k	36.1%	0.01%
3.68%	Skandinaviska Enskilda Banken AB, Private Banking, Investment Banking, and Insurance Arm	2,286,666	€394.8k	16.7%	0.01%
2.99%	Futur Pension Försäkringsaktiebolag, Asset Management Arm	1,856,230	€320.5k	24.1%	0.09%
2.98%	Nordnet AB (publ), Asset Management Arm	1,847,903	€319.0k	0.62%	0.05%
2.75%	Alzecure Discovery AB	1,710,000	€295.2k	0%	no data
2.42%	Thomas Pollare	1,501,293	€259.2k	0%	no data
1.46%	Pontus Forsell	907,477	€156.7k	0%	no data
1.41%	Johan Sandin	875,834	€151.2k	0%	no data
0.66%	Martin Jönsson	409,466	€70.7k	0%	no data
0.2%	Birgitta Lundvik	122,500	€21.1k	0%	no data
0.12%	Asarina Pharma AB (publ)	74,166	€12.8k	0%	no data
0.12%	Marta Storck	74,166	€12.8k	0%	no data
0.08%	Ragnar Linder	49,698	€8.6k	0%	no data
0.04%	Janet Hoogstraate	25,000	€4.3k	0%	no data
0.004%	Eva Lilienberg	2,500	€432.0	0%	no data